Sartorius Stedim Biotech Stock

Equities

DIM

FR0013154002

Medical Equipment, Supplies & Distribution

Real-time Euronext Paris 07:43:42 2024-04-24 am EDT 5-day change 1st Jan Change
211.3 EUR +1.25% Intraday chart for Sartorius Stedim Biotech -15.16% -11.94%
Sales 2024 * 2.96B 3.16B Sales 2025 * 3.37B 3.6B Capitalization 20.31B 21.7B
Net income 2024 * 343M 367M Net income 2025 * 459M 490M EV / Sales 2024 * 7.68 x
Net Debt 2024 * 2.27B 2.42B Net Debt 2025 * 2.15B 2.3B EV / Sales 2025 * 6.71 x
P/E ratio 2024 *
57.9 x
P/E ratio 2025 *
41.7 x
Employees 10,493
Yield 2024 *
0.36%
Yield 2025 *
0.53%
Free-Float 31.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.05%
1 week-15.16%
Current month-20.20%
1 month-22.23%
3 months-4.70%
6 months+20.03%
Current year-11.94%
More quotes
1 week
191.75
Extreme 191.75
219.70
1 month
191.75
Extreme 191.75
279.70
Current year
191.75
Extreme 191.75
281.00
1 year
160.55
Extreme 160.55
287.80
3 years
160.55
Extreme 160.55
551.00
5 years
118.10
Extreme 118.1
551.00
10 years
20.00
Extreme 20
551.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 48 19-03-25
Chairman 59 07-06-28
Chief Tech/Sci/R&D Officer 59 09-04-28
Members of the board TitleAgeSince
Director/Board Member 62 07-06-28
Chairman 59 07-06-28
Director/Board Member 67 15-04-06
More insiders
Date Price Change Volume
24-04-24 211.3 +1.25% 15 002
24-04-23 208.7 +6.21% 106,382
24-04-22 196.5 -2.04% 113,309
24-04-19 200.6 -4.29% 169,509
24-04-18 209.6 -15.69% 299,152

Real-time Euronext Paris, April 24, 2024 at 07:43 am EDT

More quotes
Sartorius Stedim Biotech is a leading provider of cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. For next generation processes, Sartorius Stedim Biotech focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. Strongly rooted in the scientific community and closely allied with customers and technology partners, the company is dedicated to its philosophy of turning science into solutions on a daily basis. With its own manufacturing and R&D sites in Europe, North America and Asia and a global network of sales companies, Sartorius Stedim Biotech enjoys a worldwide presence. Its key manufacturing and R&D site is in Germany.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
208.7 EUR
Average target price
251.3 EUR
Spread / Average Target
+20.43%
Consensus